ZILERAN Trademark

Trademark Overview

On Wednesday, January 6, 2010, a trademark application was filed for ZILERAN with the United States Patent and Trademark Office. The USPTO has given the ZILERAN trademark a serial number of 77905797. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 2, 2016. This trademark is owned by Biovail Laboratories International SRL. The ZILERAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of disorders, diseases, conditions and ailments, namely, eye drops, ophthalmic preparations, and pharmaceutical preparations for the treatment of eye diseases and the treatment of ocular disorders; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of disorders, diseases, conditions, and ailments of the central nervous system; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Parkinson's disease; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Huntington's disease; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of amyotrophic lateral sclerosis; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Alzheimer's disease; Pharmaceutical preparations and substances for the prevention, treatment and alleviation of Tourette Syndrome; Pharmace...

General Information

Serial Number77905797
Word MarkZILERAN
Filing DateWednesday, January 6, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 2, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 5, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of disorders, diseases, conditions and ailments, namely, eye drops, ophthalmic preparations, and pharmaceutical preparations for the treatment of eye diseases and the treatment of ocular disorders; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of disorders, diseases, conditions, and ailments of the central nervous system; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Parkinson's disease; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Huntington's disease; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of amyotrophic lateral sclerosis; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Alzheimer's disease; Pharmaceutical preparations and substances for the prevention, treatment and alleviation of Tourette Syndrome; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of epilepsy; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of multiple sclerosis; pharmaceutical preparations and substances for the treatment of depression, depressive disorders and mental illnesses; antidepressants; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of anxiety; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of pain; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of disorders, diseases, conditions, and ailments of the cardiovascular system; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of cardiopulmonary disorders, diseases, conditions, and ailments; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of disorders, diseases, conditions, and ailments of the circulatory system; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of hypertension, angina, high blood pressure, heart failure and ventricular dysfunction; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of metabolic disorders, diseases, conditions, and ailments; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of diabetes; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of viral and infectious diseases
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 11, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVALEANT INTERNATIONAL BERMUDA
Party Type21 - New Owner After Publication
Legal Entity Type99 - Other
AddressHAMILTON HM11
BM
Party NameBiovail Laboratories International SRL
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressChrist Church BB17154
BB
Party NameBiovail Laboratories International SRL
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressChrist Church BB17154
BB

Trademark Events

Event DateEvent Description
Friday, October 1, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, January 9, 2010NEW APPLICATION ENTERED
Monday, January 11, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 30, 2010ASSIGNED TO EXAMINER
Tuesday, April 6, 2010NON-FINAL ACTION WRITTEN
Tuesday, April 6, 2010NON-FINAL ACTION E-MAILED
Tuesday, April 6, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 1, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 1, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 15, 2011INQUIRY TO SUSPENSION E-MAILED
Tuesday, October 19, 2010SUSPENSION LETTER WRITTEN
Tuesday, October 19, 2010LETTER OF SUSPENSION E-MAILED
Tuesday, October 19, 2010NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, March 23, 2011ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, April 6, 2011ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, April 22, 2011ASSIGNED TO LIE
Thursday, April 28, 2011SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, May 11, 2011REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, September 15, 2011SUSPENSION INQUIRY WRITTEN
Thursday, September 15, 2011NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, October 29, 2012INQUIRY TO SUSPENSION E-MAILED
Monday, March 12, 2012TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, March 23, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 23, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 11, 2012SUSPENSION LETTER WRITTEN
Wednesday, April 11, 2012LETTER OF SUSPENSION E-MAILED
Wednesday, April 11, 2012NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, August 1, 2012ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, October 29, 2012SUSPENSION INQUIRY WRITTEN
Monday, October 29, 2012NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, December 12, 2013INQUIRY TO SUSPENSION E-MAILED
Saturday, April 20, 2013TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, April 29, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 29, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 20, 2013SUSPENSION LETTER WRITTEN
Monday, May 20, 2013LETTER OF SUSPENSION E-MAILED
Monday, May 20, 2013NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, November 21, 2013SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, December 12, 2013SUSPENSION INQUIRY WRITTEN
Thursday, December 12, 2013NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, January 22, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 22, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 20, 2014EXAMINER'S AMENDMENT ENTERED
Thursday, June 12, 2014TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, June 19, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 19, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 20, 2014EXAMINERS AMENDMENT -WRITTEN
Friday, June 20, 2014EXAMINERS AMENDMENT E-MAILED
Friday, June 20, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, June 28, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 30, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 21, 2015ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, March 30, 2015SOU EXTENSION 1 GRANTED
Monday, June 23, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 16, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 5, 2014PUBLISHED FOR OPPOSITION
Tuesday, August 5, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, March 30, 2015SOU TEAS EXTENSION RECEIVED
Monday, March 30, 2015SOU EXTENSION 1 FILED
Thursday, March 3, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 16, 2025ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, May 2, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Wednesday, April 1, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 18, 2015SOU TEAS EXTENSION RECEIVED
Friday, September 18, 2015SOU EXTENSION 2 FILED
Monday, September 28, 2015SOU EXTENSION 2 GRANTED
Friday, September 25, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 29, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 2, 2016ABANDONMENT - NO USE STATEMENT FILED

Related Keywords

zileran preparations treatment pharmaceutical prevention substances alleviation disease disorders diseases ailments